Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014 (2014), Article ID 635364, 11 pages
http://dx.doi.org/10.1155/2014/635364
Research Article

Bisphenol A Alters -hCG and MIF Release by Human Placenta: An In Vitro Study to Understand the Role of Endometrial Cells

1Department of Life Sciences, University of Siena, Via A. Moro 2, 53100 Siena, Italy
2Department of Reproductive Immunology and Pathology, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Tuwima 10 Street, 10-747 Olsztyn, Poland
3Department of Gynecology and Obstetrics, Faculty of Medical Sciences, University of Warmia and Masuria, Zolnierska 14 C Street, 10-561 Olsztyn, Poland

Received 15 November 2013; Revised 6 January 2014; Accepted 30 January 2014; Published 11 March 2014

Academic Editor: Graça Ferreira-Dias

Copyright © 2014 C. Mannelli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Caballero-Campo, F. Domínguez, J. Coloma et al., “Hormonal and embryonic regulation of chemokines IL-8, MCP-1 and RANTES in the human endometrium during the window of implantation,” Molecular Human Reproduction, vol. 8, no. 4, pp. 375–384, 2002. View at Google Scholar · View at Scopus
  2. W. A. Castro-Rendón, J. F. Castro-Alvarez, C. Guzmán-Martinez, and J. C. Bueno-Sanchez, “Blastocyst-endometrium interaction: intertwining a cytokine network,” Brazilian Journal Of Medical and Biological Research, vol. 39, no. 11, pp. 1373–1385, 2006. View at Google Scholar
  3. V. Saini, S. Arora, A. Yadav, and J. Bhattacharjee, “Cytokines in recurrent pregnancy loss,” Clinica Chimica Acta, vol. 412, no. 9-10, pp. 702–708, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Paulesu, J. Bhattacharjee, N. Bechi, R. Romagnoli, S. Jantra, and F. Ietta, “Pro-inflammatory cytokines in animal and human gestation,” Current Pharmaceutical Design, vol. 16, no. 32, pp. 3601–3615, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. E. Ramhorst, L. Giribaldi, L. Fraccaroli et al., “Galectin-1 confers immune privilege to human trophoblast: implications in recurrent fetal loss,” Glycobiology, vol. 22, no. 10, pp. 1374–1386, 2012. View at Google Scholar
  6. P. Viganò, M. Cintorino, F. Schatz, C. J. Lockwood, and F. Arcuri, “The role of macrophage migration inhibitory factor in maintaining the immune privilege at the fetal-maternal interface,” Seminars in Immunopathology, vol. 29, no. 2, pp. 135–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Singh, P. Chaudhry, and E. Asselin, “Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors,” Journal of Endocrinology, vol. 210, no. 1, pp. 5–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. W. R. Schaefer, L. Fischer, W. R. Deppert et al., “In vitro-Ishikawa cell test for assessing tissue-specific chemical effects on human endometrium,” Reproductive Toxicology, vol. 30, no. 1, pp. 89–93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Sharkey and S. K. Smith, “The endometrium as a cause of implantation failure,” Best Practice and Research, vol. 17, no. 2, pp. 289–307, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. R. G. Berger, W. G. Foster, and D. deCatanzaro, “Bisphenol-A exposure during the period of blastocyst implantation alters uterine morphology and perturbs measures of estrogen and progesterone receptor expression in mice,” Reproductive Toxicology, vol. 30, no. 3, pp. 393–400, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Miyakoshi, K. Miyajima, S. Takekoshi, and R. Y. Osamura, “The influence of endocrine disrupting chemicals on the proliferation of ERα knockdown-human breast cancer cell line MCF-7; new attempts by RNAi technology,” Acta Histochemica et Cytochemica, vol. 42, no. 2, pp. 23–28, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Nakamura, Y. Katsu, H. Watanabe, and T. Iguchi, “Estrogen receptor subtypes selectively mediate female mouse reproductive abnormalities induced by neonatal exposure to estrogenic chemicals,” Toxicology, vol. 253, no. 1–3, pp. 117–124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Ietta, Y. Wu, R. Romagnoli et al., “Oxygen regulation of macrophage migration inhibitory factor in human placenta,” American Journal of Physiology—Endocrinology and Metabolism, vol. 292, no. 1, pp. E272–E280, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Ietta, N. Bechi, R. Romagnoli et al., “17β-estradiol modulates the macrophage migration inhibitory factor secretory pathway by regulating ABCA1 expression in human first-trimester placenta,” American Journal of Physiology—Endocrinology and Metabolism, vol. 298, no. 3, pp. E411–E418, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. B. D. Pearce, S. E. Garvin, J. Grove et al., “Serum macrophage migration inhibitory factor in the prediction of preterm delivery,” American Journal of Obstetrics and Gynecology, vol. 199, no. 1, pp. 46.e1–46.e6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. B. D. Pearce, J. Grove, E. A. Bonney et al., “Interrelationship of cytokines, hypothalamic-pituitary-adrenal axis hormones, and psychosocial variables in the prediction of preterm birth,” Gynecologic and Obstetric Investigation, vol. 70, no. 1, pp. 40–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Todros, S. Bontempo, E. Piccoli et al., “Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 123, no. 2, pp. 162–166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Yamada, E. H. Kato, M. Morikawa et al., “Decreased serum levels of macrophage migration inhibition factor in miscarriages with normal chromosome karyotype,” Human Reproduction, vol. 18, no. 3, pp. 616–620, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. L. A. Cole, “New discoveries on the biology and detection of human chorionic gonadotropin,” Reproductive Biology and Endocrinology, vol. 7, article 8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Handschuh, J. Guibourdenche, M. Cocquebert et al., “Expression and regulation by PPARγ of hCG α- and β-subunits: comparison between Villous and Invasive Extravillous Trophoblastic Cells,” Placenta, vol. 30, no. 12, pp. 1016–1022, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Tsampalas, V. Gridelet, S. Berndt, J. Foidart, V. Geenen, and S. P. d'Hauterive, “Human chorionic gonadotropin: a hormone with immunological and angiogenic properties,” Journal of Reproductive Immunology, vol. 85, no. 1, pp. 93–98, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Huppertz, V. M. Berghold, R. Kawaguchi, and M. Gauster, “A variety of opportunities for immune interactions during trophoblast development and invasion,” American Journal of Reproductive Immunology, vol. 67, no. 5, pp. 349–357, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Arcuri, M. Cintorino, A. Carducci et al., “Human decidual natural killer cells as a source and target of macrophage migration inhibitory factor,” Reproduction, vol. 131, no. 1, pp. 175–182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. Calafat, X. Ye, L. Wong, J. A. Reidy, and L. L. Needham, “Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004,” Environmental Health Perspectives, vol. 116, no. 1, pp. 39–44, 2008. View at Google Scholar · View at Scopus
  25. B. S. Rubin, “Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects,” Journal of Steroid Biochemistry and Molecular Biology, vol. 127, no. 1-2, pp. 27–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. L. N. Vandenberg, I. Chahoud, J. J. Heindel, V. Padmanabhan, F. J. R. Paumgartten, and G. Schoenfelder, “Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A,” Ciencia e Saude Coletiva, vol. 17, no. 2, pp. 407–434, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Bolli, P. Galluzzo, P. Ascenzi et al., “Laccase treatment impairs bisphenol A-induced cancer cell proliferation affecting estrogen receptor α-dependent rapid signals,” IUBMB Life, vol. 60, no. 12, pp. 843–852, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Bolli, P. Bulzomi, P. Galluzzo, F. Acconcia, and M. Marino, “Bisphenol a impairs estradiol-induced protective effects against DLD-1 colon cancer cell growth,” IUBMB Life, vol. 62, no. 9, pp. 684–687, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. G. G. J. M. Kuiper, J. G. Lemmen, B. Carlsson et al., “Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β,” Endocrinology, vol. 139, no. 10, pp. 4252–4263, 1998. View at Google Scholar · View at Scopus
  30. M. E. Baker and C. Chandsawangbhuwana, “3D models of MBP, a biologically active metabolite of bisphenol A, in human estrogen receptor α and estrogen receptor β,” PloS ONE, vol. 7, no. 10, Article ID e46078, 2012. View at Google Scholar
  31. A. Bouskine, M. Nebout, F. Brücker-Davis, M. Banahmed, and P. Fenichel, “Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor,” Environmental Health Perspectives, vol. 117, no. 7, pp. 1053–1058, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Fischer, W. R. Deppert, D. Pfeifer et al., “Potential hazards to embryo implantation: a human endometrial in vitro model to identify unwanted antigestagenic actions of chemicals,” Toxicology and Applied Pharmacology, vol. 260, no. 3, pp. 232–240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. T. J. Mørck, G. Sorda, N. Bechi et al., “Placental transport and in vitro effects of bisphenol A,” Reproductive Toxicology, vol. 30, no. 1, pp. 131–137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Liu, P. Yu, W. Qian et al., “Perinatal bisphenol A exposure and adult glucose homeostasis: identifying critical windows of exposure,” PloS ONE, vol. 8, no. 5, Article ID e64143, 2013. View at Google Scholar
  35. J. D. Meeker, “Exposure to environmental endocrine disruptors and child development,” Archives of Pediatrics and Adolescent Medicine, vol. 166, no. 10, pp. 952–958, 2012. View at Google Scholar
  36. J. Varayoud, J. G. Ramos, V. L. Bosquiazzo, M. Muñoz-de-Toro, and E. H. Luque, “Developmental exposure to bisphenol a impairs the uterine response to ovarian steroids in the adult,” Endocrinology, vol. 149, no. 11, pp. 5848–5860, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Noyes, A. Hertig, and J. Rock, “Dating the endometrial biopsy: obstetrical & gynecological survey,” Gynecology, vol. 5, no. 4, pp. 561–564, 1950. View at Google Scholar
  38. S. Hombach-Klonisch, A. Kehlen, P. A. Fowler et al., “Regulation of functional steroid receptors and ligand-induced responses in telomerase-immortalized human endometrial epithelial cells,” Journal of Molecular Endocrinology, vol. 34, no. 2, pp. 517–534, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Kodama, O. Yoshino, Y. Osuga et al., “Progesterone decreases bone morphogenetic protein (BMP) 7 expression and BMP7 inhibits decidualization and proliferation in endometrial stromal cells,” Human Reproduction, vol. 25, no. 3, pp. 751–756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. C. Schutte and R. N. Taylor, “A tissue-engineered human endometrial stroma that responds to cues for secretory differentiation, decidualization, and menstruation,” Fertility and Sterility, vol. 97, no. 4, pp. 997–1003, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. J. R. Malayer and V. M. Woods, “Expression of estrogen receptor and maintenance of hormone-responsive phenotype in bovine fetal uterine cells,” Domestic Animal Endocrinology, vol. 15, no. 3, pp. 141–154, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Saso, S. Shields, Y. Zuo, and C. Chakraborty, “Role of Rho GTPases in human trophoblast migration induced by IGFBP1,” Biology of Reproduction, vol. 86, no. 1, article 24, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. O. Genbacev, T. E. K. White, C. E. Gavin, and R. K. Miller, “Human trophoblast cultures: models for implantation and peri-implantation toxicology,” Reproductive Toxicology, vol. 7, supplement 1, pp. 75–94, 1993. View at Google Scholar · View at Scopus
  44. W.-G. Cao, M. Morin, C. Metz, R. Maheux, and A. Akoum, “Stimulation of macrophage migration inhibitory factor expression in endometrial stromal cells by interleukin 1, beta involving the nuclear transcription factor NFκB,” Biology of Reproduction, vol. 73, no. 3, pp. 565–570, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. He, M. Miao, L. J. Herrinton et al., “Bisphenol A levels in blood and urine in a Chinese population and the personal factors affecting the levels,” Environmental Research, vol. 109, no. 5, pp. 629–633, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Ikezuki, O. Tsutsumi, Y. Takai, Y. Kamei, and Y. Taketani, “Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure,” Human Reproduction, vol. 17, no. 11, pp. 2839–2841, 2002. View at Google Scholar · View at Scopus
  47. J. Matsumoto, H. Iwano, H. Inoue, N. Iwano, N. Yamashiki, and H. Yokota, “Metabolic barrier against bisphenol A in rat uterine endometrium,” Toxicological Sciences, vol. 99, no. 1, pp. 118–125, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. X. L. Cao, J. Zhang, C. G. Goodyer, S. Hayward, G. M. Cooke, and I. H. A. Curran, “Bisphenol A in human placental and fetal liver tissues collected from Greater Montreal area (Quebec) during 1998–2008,” Chemosphere, vol. 89, no. 5, pp. 505–511, 2012. View at Google Scholar
  49. S. Yoshihara, T. Mizutare, M. Makishima et al., “Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency,” Toxicological Sciences, vol. 78, no. 1, pp. 50–59, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Chan, E. H. Rabbitt, B. A. Innes et al., “Glucocorticoid-induced apoptosis in human decidua: a novel role for 11β-hydroxysteroid dehydrogenase in late gestation,” Journal of Endocrinology, vol. 195, no. 1, pp. 7–15, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Hevir, J. Šinkovec, and T. L. Rižner, “Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT,” Molecular and Cellular Endocrinology, vol. 331, no. 1, pp. 158–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Hukkanen, M. Mäntylä, L. Kangas et al., “Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium,” Pharmacology and Toxicology, vol. 82, no. 2, pp. 93–97, 1998. View at Google Scholar · View at Scopus
  53. X. Fei, C. Song, and H. Gao, “Transmembrane transports of acrylamide and bisphenol A and effects on development of zebrafish (Danio rerio),” Journal of Hazardous Materials, vol. 184, no. 1–3, pp. 81–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Bechi, F. Ietta, R. Romagnoli et al., “Estrogen-like response to p-nonylphenol in human first trimester placenta and BeWo choriocarcinoma cells,” Toxicological Sciences, vol. 93, no. 1, pp. 75–81, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. N. Bechi, F. Ietta, R. Romagnoli et al., “Environmental levels of para-nonylphenol are able to affect cytokine secretion in human placenta,” Environmental Health Perspectives, vol. 118, no. 3, pp. 427–431, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Bourdiec, R. Shao, C. V. Rao, and A. Akoum, “Human chorionic gonadotropin triggers angiogenesis via the modulation of endometrial stromal cell responsiveness to interleukin 1: a new possible mechanism underlying embryo implantation,” Biology of Reproduction, vol. 87, no. 3, p. 66, 2012. View at Google Scholar
  57. D. Herr, H. M. Fraser, R. Konrad, I. Holzheu, R. Kreienberg, and C. Wulff, “Human chorionic gonadotropin controls luteal vascular permeability via vascular endothelial growth factor by down-regulation of a cascade of adhesion proteins,” Fertility and Sterility, vol. 99, no. 6, pp. 1749–1758, 2013. View at Google Scholar
  58. Z. Iliodromiti, N. Antonakopoulos, S. Sifakis et al., “Endocrine, paracrine, and autocrine placental mediators in labor,” Hormones, vol. 11, no. 4, pp. 397–409, 2012. View at Google Scholar
  59. W. Norris, T. Nevers, S. Sharma, and S. Kalkunte, “Review: HCG, preeclampsia and regulatory T cells,” Placenta, vol. 32, supplement 2, pp. S182–S185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Rolfo, D. Giuffrida, A. M. Nuzzo et al., “Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia,” PLoS ONE, vol. 8, no. 3, Article ID e59403, 2013. View at Google Scholar
  61. S. Cardaropoli, L. Paulesu, R. Romagnoli et al., “Macrophage migration inhibitory factor in fetoplacental tissues from preeclamptic pregnancies with or without fetal growth restriction,” Clinical and Developmental Immunology, vol. 2012, Article ID 639342, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus